Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France)

Vaccine

Volumn 31, Issue 32, 2013, Pages 3222-3228

  Gessner, Bradford D ^a   Brooks, W Abdullah ^b,c   Neuzil, Kathleen M ^d   Vernet, Guy ^e,j   Bright, Rick A ^f   Tam, John S ^g   Bresee, Joseph ^h   Monto, Arnold S ⁱ  

^a Agence de Medecine Preventive   (France)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d PATH   (United States)

^e Fondation Mérieux Applied Research   (France)

^f U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j CENTRE PASTEUR DU CAMEROUN   (Cameroon)

more..

Author keywords

Clinical trial; Conference report; Disease burden; Immunization; Influenza; Vaccinea

Indexed keywords

INFLUENZA VACCINE;

CHILD; CONFERENCE PAPER; FRANCE; GROUPS BY AGE; HAEMOPHILUS INFLUENZAE TYPE B; HIGH RISK POPULATION; HUMAN; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; LOWEST INCOME GROUP; METHODOLOGY; PREGNANT WOMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADULT; CHILD; CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; COST OF ILLNESS; DEVELOPING COUNTRIES; EPIDEMIOLOGICAL MONITORING; FEMALE; FRANCE; HEALTH RESOURCES; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PUBLIC HEALTH; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 84879460253     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.017     Document Type: Conference Paper

References (43)

1. Madhi S.A., Klugman K.P. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nature Med 2004, 10:811-813.
2. Forgie I.M., Campbell H., Lloyd-Evans N., Leinonen M., O'Neill K.P., Saikku P., et al. Etiology of acute lower respiratory tract infections in children in a rural community in The Gambia. Pediatr Infect Dis J 1992, 11:466-473.
3. McCullers J.A., McAuley J.L., Browall S., Iverson A.R., Boyd K.L. Henriques Normark B, influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 2010, 202:1287-1295.
4. Peltola V.T., Murti K.G., McCullers J.A. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 2005, 192:249-257.
5. Gessner B.D., Sutanto A., Linehan M., Djelantik I.G., Fletcher T., Gerudug I.K., et al. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet 2005, 365:43-52.
6. Qureshi H., Gessner B.D., Leboulleux D., Hasan H., Alam S.E., Moulton L.H. The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia. Vaccine 2000, 18:2956-2962.
7. Cutts F.T., Zaman S.M., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365:1139-1146.
8. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003, 349:1341-1348.
9. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:606-614.
10. Feikin D.R., Laserson K.F., Ojwando J., Nyambane G., Ssempijja V., Audi A., et al. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya. Vaccine 2012, 30(Suppl. 1):A52-A60.
11. Radin J.M., Katz M.A., Tempia S., Talla Nzussouo N., Davis R., Duque J., et al. Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis 2012, 2006(Suppl. 1):S14-S21.
12. Nair H., Simooes E.A., Rudan I., Gessner B.D., Azziz-Baumgartner E., Zhang J.S., et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 2013, 381:1380-1390.
13. Chalmers T.C., Smith H., Blackburn B., Silverman B., Schroeder B., Reitman D., et al. A method for assessing the quality of a randomized control trial. Contr Clin Trials 1981, 2:31-49.
14. Victora C.G., Wagstaff A., Schellenberg J.A., Gwatkin D., Claeson M., Habicht J.P. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet 2003, 362:233-241.
15. Levine O.S., O'Brien K.L., Deloria-Knoll M., Murdoch D.R., Feikin D.R., DeLuca A.N., et al. The pneumonia etiology research for child health project: a 21st century childhood pneumonia etiology study. Clin Infect Dis 2012, 54(Suppl. 2):S93-S101.
16. Hammitt L.L., Kazungu S., Morpeth S.C., Gibson D.G., Mvera B., Brent A.J., et al. A preliminary study of pneumonia etiology among hospitalized children in Kenya. Clin Infect Dis 2012, 54(Suppl. 2):S190-S199.
17. Mermond S., Zurawski V., D'Ortenzio E., Driscoll A.J., DeLuca A.N., Deloria-Knoll M., et al. Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the pneumonia etiolgy research for child health project. Clin Infect Dis 2012, 54(Suppl. 2):S180-S189.
18. Brooks W.A., Breiman R.F., Goswami D., Hossain A., Alam K., Saha S.K., et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 2007, 77:795-801.
19. Brooks W.A., Goswami D., Rahman M., Nahar K., Fry A.M., Balish A., et al. Influenza is a major contributor to childhood pneumonia in a tropical developing country. Pediatr Infect Dis J 2010, 29:216-221.
20. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
21. Ortiz J.R., Neuzil K.M., Ahonkhai V.I., Gellin B.G., Salisbury D.M., Read J.S., et al. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine 2012, 30:7134-7140.
22. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564.
23. Englund J., Glezen W.P., Piedra P.A. Maternal immunization against viral disease. Vaccine 1998, 16:1456-1463.
24. Munoz F.M., Piedra P.A., Glezen W.P. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 2003, 21:3465-3467.
25. Lanata C.F., Rudan I., Boschi-Pinto C., Tomaskovic L., Cherian T., Weber M., et al. Methodological and quality issues in epidemiological studies of acute lower respiratory infections in children in developing countries. Int J Epidemiol 2004, 33:1362-1372.
26. Vesikari T., Knuf M., Wutzler P., Karvonen A., Kieninger-Baum D., Schmitt H.J., et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011, 365:1406-1416.
27. Domachowske J.B., Pankow-Culot H., Bautista M., Feng Y., Claeys C., Peeters M., et al. Randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis 2013, 207:1878-1887.
28. Ambrose C.S., Yi T., Walker R.E., Connor E.M. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J 2008, 27:744-748.
29. Ashkenazi S., Vertruyen A., Aristegui J., Esposito S., McKeith D.D., Klemola T., et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006, 25:870-879.
30. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356:685-696.
31. Arnoux S., Weinberger C., Gessner B.D. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use. Vaccine 2007, 25:7720-7731.
32. Hasan K., Jolly P., Marquis G., Roy E., Podder G., Alam K., et al. Viral etiology of pneumonia in a cohort of newborns till 24 months of age in Rural Mirzapur, Bangladesh. Scand J Infect Dis 2006, 38:690-695.
33. Forgie I.M., O'Neill K.P., Lloyd-Evans N., Leinonen M., Campbell H., Whittle H.C., et al. Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J 1991, 10:42-47.
34. Noyola D.E., Rodriguez-Moreno G., Sanchez-Alvarado J., Martinez-Wagner R., Ochoa-Zavala J.R. Viral etiology of lower respiratory tract infections in hospitalized children in Mexico. Pediatr Infect Dis J 2004, 23:118-123.
35. Samransamruajkit R., Hiranrat T., Chieochansin T., Sritippayawan S., Deerojanawong J., Prapphal N., et al. Prevalence, clinical presentations and complications among hospitalized children with influenza pneumonia. Jpn J Infect Dis 2008, 61:446-449.
36. Yoshida L.M., Suzuki M., Yamamoto T., Nguyen H.A., Nguyen C.D., Nguyen A.T., et al. Viral pathogens associated with acute respiratory infections in central vietnamese children. Pediatr Infect Dis J 2010, 29:75-77.
37. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006, 19:571-582.
38. Peltola V.T., McCullers J.A. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 2004, 23:S87-S97.
39. McCullers J.A., Bartmess K.C. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003, 187:1000-1009.
40. O'Brien K.L., Walters M.I., Sellman J., Quinlisk P., Regnery H., Schwartz B., et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 2000, 30:784-789.
41. Madhi S.A., Dittmer S., Kuwanda L., Venter M., Cassim H., Lazarus E., et al. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized double-blind, placebo controlled trial. AIDS 2013, 27:369-379.
42. Durier C., Desaint C., Lucht F., Girard P.M., Levy Y., May T., et al. Lont-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults. AIDS 2013, 27:87-93.
43. Adegbola R., Nesin M., Wairagkar N. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am J Obstet Gynecol 2012, 207:S28-S32.